Burkitt lymphoma is the fastest growing cancer known to medicine, with a tumor doubling time of roughly 24 hours. That means the mass of cancer cells can double in size in a single day, making it one of the most aggressive malignancies ever documented. But “fastest growing” can mean different things depending on context: the speed at which a tumor physically expands inside the body, or which cancers are increasing most rapidly in new diagnoses across the population. Both answers matter, and they point to very different cancers.
Burkitt Lymphoma: The Fastest Biological Growth
Burkitt lymphoma is a type of blood cancer that originates in white blood cells called B-lymphocytes. Its 24-hour doubling time is extraordinary. For comparison, most solid tumors double over weeks or months. This speed means a small cluster of Burkitt lymphoma cells can become a visible, aggressive mass in days rather than the months or years typical of other cancers.
One way pathologists measure how quickly cancer cells are dividing is through a protein called Ki-67, which is present only in cells that are actively reproducing. Burkitt lymphoma cells show Ki-67 activity in nearly 100% of the tumor, meaning virtually every cell is dividing at any given moment. Most cancers have Ki-67 levels far below that threshold. This marker has become a standard tool for grading tumor aggressiveness across many cancer types.
Despite its terrifying growth speed, Burkitt lymphoma is paradoxically one of the more treatable aggressive cancers, particularly in children. Because the cells are dividing so rapidly, they are highly sensitive to chemotherapy, which targets dividing cells. The very trait that makes it dangerous also makes it vulnerable to treatment.
Other Cancers With Rapid Tumor Growth
Several other cancers are notable for how quickly they grow or spread, even if they don’t match Burkitt lymphoma’s raw doubling time.
Small cell lung cancer is considered the prototype of rapidly growing solid tumors. Its doubling time ranges from 25 to 217 days depending on the study, with an average around 86 days. That may sound slow compared to Burkitt lymphoma, but for a solid organ tumor it’s remarkably fast. Small cell lung cancer accounts for about 10-15% of all lung cancers and is strongly linked to smoking. By the time it’s diagnosed, it has typically already spread beyond the lungs.
Glioblastoma, the most aggressive primary brain tumor in adults, grows rapidly within the confined space of the skull. Even after surgery and treatment, more than 90% of glioblastomas recur at the original site, with a median time to recurrence of just 6.9 months. Its tendency to infiltrate surrounding brain tissue makes complete removal nearly impossible.
Inflammatory breast cancer stands out for the speed at which it announces itself. Unlike most breast cancers that grow as a slow lump, inflammatory breast cancer changes the appearance of the breast over the course of just several weeks. The skin may become red, swollen, or dimpled, resembling an infection. For a diagnosis of inflammatory breast cancer, these symptoms must have been present for less than six months, reflecting how recently the disease appeared.
Cancers That Hide Before They Hurry
Some cancers spend years growing silently before entering an aggressive phase, which creates a misleading impression of sudden onset. Pancreatic cancer is the clearest example. Research based on genetic mutation analysis suggests that pancreatic cancers may be confined to the pancreas for a decade or more before spreading. The problem is that the early growth is undetectable. A single cancer cell needs to undergo many doublings just to become a one-centimeter tumor containing roughly one billion cells. But once it reaches that size, only a few more doublings are needed to become advanced-stage disease. Once pancreatic cancer is detectable, its doubling time is estimated at 40 to 60 days.
This pattern explains why pancreatic cancer is so often caught late. The long silent phase offers a theoretical window for early detection, but current screening tools aren’t sensitive enough to find it during those years of hidden growth.
Fast-Growing Cancers in Children
Childhood cancers tend to grow faster than adult cancers in general, and neuroblastoma is a striking example. This cancer of nerve tissue, which most commonly affects children under five, has a median cell population doubling time of about 4.2 days (roughly 101 hours). Nephroblastoma, a kidney cancer in children also known as Wilms tumor, doubles somewhat more slowly at a median of 7.8 days. Both are dramatically faster than typical adult solid tumors, which may take months to double.
As with Burkitt lymphoma, this rapid growth in pediatric cancers often makes them more responsive to chemotherapy. Childhood cancers as a group have significantly higher cure rates than most adult cancers, in part because fast-dividing cells are easier to kill with treatment.
Which Cancers Are Rising Fastest in New Cases
The phrase “fastest growing cancer” also commonly refers to which cancers are increasing most in the population. Data from the National Cancer Institute’s SEER program covering 2017 to 2021 shows distinct patterns by sex.
Among men, prostate cancer had the fastest rising incidence, increasing an average of 2.9% per year. Five other cancers also rose in men during this period: pancreatic, oral cavity and pharynx, kidney, myeloma, and testicular cancers. Among women, stomach cancer rose the fastest at an average of 3.2% per year. Seven other cancers increased in women, including breast, uterine, liver, melanoma, pancreatic, myeloma, and oral cavity cancers.
On the positive side, lung cancer incidence dropped faster than any other type in both men and women, falling 3.4% per year in men and 2.1% per year in women. This decline reflects decades of reduced smoking rates and improved screening. The rising rates of other cancers, particularly uterine and prostate cancers, are partly driven by changes in detection practices and partly by factors like increasing obesity rates and shifts in population demographics.
Why Growth Speed Matters for Treatment
A cancer’s growth rate shapes nearly every aspect of how it’s managed: how urgently treatment needs to start, which therapies are likely to work, and what the expected outcome looks like. Faster-growing cancers generally require more immediate and intensive treatment, but they also tend to respond more dramatically to chemotherapy. Slow-growing cancers can be harder to treat precisely because their cells aren’t dividing fast enough for chemotherapy to catch them in the act.
This is why some of the “scariest” fast-growing cancers, like Burkitt lymphoma, actually have better outcomes than slower cancers like pancreatic adenocarcinoma. Speed of growth alone doesn’t determine how dangerous a cancer is. What matters is the combination of growth rate, location, how early it’s caught, and how well it responds to available treatments.